CD5 and myeloid sarcoma: The percentage of CD19+CD27−IgD+ naïve B cells with a CD5+CD1d+ Breg phenotype increased in MS as well (Figure 2F), demonstrating that this increase in naïve Breg number is not directly related to the increase in total MS B cells.